Presentation ESC 2022 Percutaneous Revascularisation for Ischaemic Left Ventricular Dysfunction Presenter: Divaka Perera August 27, 2022 REGISTER for free or LOG IN to view this content Coronary Heart Failure Presentation ESC 2022 Up Next Presentation ESC 2022 Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction Presenter: John H. Alexander August 28, 2022 More slides + Presentation ESC 2022 Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) Presenter: Wilfried Mullens August 29, 2022 Presentation ESC 2022 DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults Presenter: Niklas Dyrby Johansen August 29, 2022 We Recommend
Presentation ESC 2022 Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction Presenter: John H. Alexander August 28, 2022
Presentation ESC 2022 Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) Presenter: Wilfried Mullens August 29, 2022
Presentation ESC 2022 DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults Presenter: Niklas Dyrby Johansen August 29, 2022